Clinical Trials Logo

Clinical Trial Summary

- Addiction to drugs and alcohol is increasingly becoming a worldwide trend that is prevalent in both rich and poor countries . Substance abuse shows a significant warming to the health, social and economic build of families, communities and nations. Extent of worldwide psychoactive substance use is estimated at 2 billion alcohol users and 185 million drug users .

- Substance abuse (including alcohol and drugs) is an important risk factor for poor health globally due to their intoxicating effects or their toxic effects on organs and tissues that lead to the development of diseases, injuries and other health conditions

- Drug abuse is associated with the increased risk of cardiovascular diseases. A study on the need for hospitalization in approximately 4800 drug users found that 223 of these were admitted to hospital due to cardiovascular diseases .

- The majority of abused substances or their metabolites are excreted through the kidneys and renal complications of drug abuse are very common .The involvement of the kidney due to drug abuse is either attributed to their elimination through the kidney, or a direct nephrotoxic effect. The damage may be acute and reversible, or chronic and can leads to end stage renal failure .

- Addiction is responsible for different types of liver diseases including fatty liver, hepatitis and liver failure. . Intravenous drug addiction by sharing of contaminated needle is very important risk factor for the development of liver diseases, particularly hepatitis B and hepatitis C. Globally, 90% of new hepatitis C infections are attributed to drug injection . In the long run, substance abuse has negative effects on sexual functions and leads to the onset of sexual disorders. .

- Long term use of alcohol was reported to inhibit of hypothalamic-pituitary-adrenal axis and reduces the release of gonadotropins from the pituitary . Morphine administration suppresses LH release and reduces the levels of testosterone, which affects testicular function.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03206411
Study type Observational
Source Assiut University
Contact Sarah A. Mohammed
Phone 0201062031286
Email Sara_abdelsamee@yahoo.com
Status Recruiting
Phase N/A
Start date December 1, 2016
Completion date November 30, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04599270 - Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers N/A
Recruiting NCT05730504 - Evaluating the Effectiveness of Mobile Self-guided Psychological Interventions to Reduce Relapse in Substance Use Disorder N/A
Completed NCT05794438 - Gamified Adaptive Approach Bias Modification on Individuals With Methamphetamine Use History N/A
Recruiting NCT05434416 - The Efficacy of a Mobile Application in Reducing Craving and Lapse Risk in Alcohol and Stimulants Problematic Use N/A
Recruiting NCT06076512 - Pain Clinic Provides Public Health Safety
Recruiting NCT05854667 - Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users Phase 2
Completed NCT04343339 - Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment